| Name | Title | Contact Details |
|---|
We are a full-service agency providing insurance in personal, business, bonding, farm, life, and flood. Our staff has over 400 years of experience. We pride ourselves on customer service and knowledge of the products we offer. Stop in to one of our North Dakota or Minnesota locations.
Segerstrom Center for the Arts is a leading performing arts complex located in Costa Mesa, California. Established in 1986 and renamed in 2011, it spans 14 acres and is recognized as Orange County’s largest non-profit arts organization. The Center features multiple venues, including Segerstrom Hall, Renée and Henry Segerstrom Concert Hall, Samueli Theater, and Judy Morr Theater, hosting a wide range of performances. The Center offers live performances that include Broadway shows, classical concerts, dance, and contemporary acts. It also provides venue rentals for private events and seminars, along with arts-based education programs through the Lawrence and Kristina Dodge Education Center. With a mission focused on artistic excellence and community engagement, the Center has welcomed over 20 million visitors and premiered over 60 world-class productions since its inception.
Every purpose-driven brand has a story worth sharing. Storykind ensures your message reaches the right audience, at the right time, and in the right way. We turn inertia into action and audiences into advocates—growing your brand for a better, kinder world. Contact us at hello@storykind.com.
Grenova™ is an innovative company that is revolutionizing lab consumables through high-quality waste reduction solutions. Our mission is to lower costs in the laboratory industry and reduce biohazard waste in the environment by delivering groundbreaking approaches in dealing with plastic consumables. Every year, over 5 million pounds of plastic pipette tips are disposed of in landfills globally after a single use. This drives significant environmental pollution and unnecessary costs. The typical laboratory consumes several thousand pipette tips every day for samples and assay procedures, due to the lack of options for safely cleaning plastic consumables. Such high consumption of plastic tips adds $25,000 to $1.5 million in annual operational costs for laboratories worldwide. At Grenova™, we know that high consumption of plastic tips is an excessive, avoidable operational cost for companies and a significant contributor to environmental pollution. This is why we decided to create devices that enable labs to wash and recycle pipette tips in large quantities. Grenova devices offer labs the option to reuse plastic tips several times, cutting associated costs by up to 90%. Grenova devices are safe for both the user and the environment, without producing hazardous waste or gases.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.